MACKAY SHIELDS LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2021$110,000
+5.8%
110,0000.0%0.00%0.0%
Q1 2021$104,000
+1.0%
110,0000.0%0.00%0.0%
Q4 2020$103,0000.0%110,0000.0%0.00%0.0%
Q3 2020$103,000
+2.0%
110,0000.0%0.00%0.0%
Q2 2020$101,000
+3.1%
110,0000.0%0.00%0.0%
Q1 2020$98,000
+2.1%
110,0000.0%0.00%0.0%
Q4 2019$96,000
-82.5%
110,000
-82.5%
0.00%
-66.7%
Q3 2019$550,000
-2.1%
630,0000.0%0.00%
-25.0%
Q2 2019$562,000
+15.6%
630,000
+21.2%
0.00%0.0%
Q1 2019$486,000
-29.9%
520,000
-37.0%
0.00%
-33.3%
Q4 2018$693,000
-10.5%
825,0000.0%0.01%0.0%
Q3 2018$774,000
-13.1%
825,0000.0%0.01%0.0%
Q2 2018$891,000
+16.0%
825,000
+25.0%
0.01%
+20.0%
Q1 2018$768,000
-13.8%
660,0000.0%0.01%
-84.8%
Q4 2017$891,000
+60.0%
660,000
+83.3%
0.03%
+57.1%
Q3 2017$557,000360,0000.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
QVT Financial LP 43,295,000$29,665,0001.82%
Telemetry Investments, L.L.C. 7,000,000$4,747,0001.38%
Baker Brothers Advisors 129,300,000$87,801,0000.93%
Castle Creek Arbitrage, LLC 5,500,000$3,755,0000.30%
WOLVERINE ASSET MANAGEMENT LLC 14,300,000$9,730,0000.28%
Verition Fund Management LLC 1,966,000$1,343,0000.22%
UBS OCONNOR LLC 11,625,000$7,960,000,0000.15%
CAPSTONE INVESTMENT ADVISORS, LLC 6,000,000$4,106,0000.12%
PFM Health Sciences, LP 4,747,000$3,243,0000.10%
ARROWGRASS CAPITAL PARTNERS (US) LP 11,500$3,568,0000.04%
View complete list of CLOVIS ONCOLOGY INC shareholders